Gefitinib Avansor

Gefitinib Avansor is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to therapy.

Gefitinib Avansor is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC where other treatments have not been effective.

Common effects of Gefitinib Avansor may include skin rash, diarrhea, and fatigue. Some users may also experience nausea or loss of appetite. These effects can vary in severity and duration, and it's important to monitor any persistent or severe symptoms.

Gefitinib Avansor should be handled with care, especially by pregnant women or those planning to become pregnant, as it may cause harm to an unborn baby. It is also important to inform healthcare providers about any existing medical conditions or allergies before starting this medication. Proper storage and administration guidelines should be followed to ensure safety.

Gefitinib Avansor may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to avoid grapefruit or grapefruit juice, as they can affect the metabolism of this medication. Always consult a healthcare provider before starting or stopping any medications while on Gefitinib Avansor.